Design of a targeted next‐generation DNA sequencing panel for pediatric T‐cell lymphoblastic lymphoma to unravel biology and optimize treatment

Low incidence and molecular heterogeneity of pediatric T‐cell lymphoblastic lymphoma (T‐LBL) require an international, large‐scale effort to identify novel clinical biomarkers. The ongoing international clinical trial LBL2018 (NCT04043494) represents an ideal opportunity to implement a common analyt...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Genes chromosomes & cancer Ročník 61; číslo 8; s. 459 - 470
Hlavní autoři: Ruether, Charlotte, Wuensch, Christian, Randau, Gerrit, Michgehl, Ulf, Trautmann, Marcel, Hartmann, Wolfgang, Sandmann, Sarah, Dugas, Martin, Khanam, Tasneem, Burkhardt, Birgit
Médium: Journal Article
Jazyk:angličtina
Vydáno: Hoboken, USA John Wiley & Sons, Inc 01.08.2022
Wiley Subscription Services, Inc
Témata:
1-Phosphatidylinositol 3-kinase
AKT protein
Biology
Cell cycle
Child
clinical trials
Deoxyribonucleic acid
DNA
DNA repair
DNA sequencing
Epigenesis, Genetic
Epigenetics
Gene regulation
Genes
High-Throughput Nucleotide Sequencing
Humans
lymphoblastic lymphoma
Lymphoma
Lymphoma, T-Cell - genetics
Mutation
Neoplasm Recurrence, Local - genetics
pediatric oncology
Pediatrics
Phosphatidylinositol 3-Kinases - genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - genetics
Proto-Oncogene Proteins c-akt - genetics
Sequence Analysis, DNA
T-Lymphocytes
targeted gene panel
variant classification
variant classification
clinical trials
targeted gene panel
pediatric oncology
lymphoblastic lymphoma
ISSN:1045-2257, 1098-2264, 1098-2264
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Low incidence and molecular heterogeneity of pediatric T‐cell lymphoblastic lymphoma (T‐LBL) require an international, large‐scale effort to identify novel clinical biomarkers. The ongoing international clinical trial LBL2018 (NCT04043494) represents an ideal opportunity to implement a common analytic approach. Targeted next‐generation sequencing is well‐suited for this purpose; however, selection of relevant target genes for T‐LBL remains subject of ongoing debates. Our group has recently designed and evaluated a first target panel of 80 candidate genes for T‐LBL. The present study aimed at developing a novel optimized gene panel for large‐scale application and to promote an international agreement on a common core panel. Small sequence variants obtained from our former study were systematically analyzed and classified with regards to pathogenic relevance, to prioritize candidate genes. Additional genes were curated from literature and online databases for a more comprehensive analysis of relevant functions and signaling pathways. The new target panel TGP‐T‐LBL entails 84 candidate genes which are key actors in NOTCH, PI3K‐AKT, JAK–STAT, RAS signaling, epigenetic regulation, transcription, DNA repair, cell cycle regulation, and ribosomal function. From our former gene panel, 35 out of 80 candidate genes were selected for the novel panel. Forty‐six out of 84 genes are currently being analyzed in the ongoing international trial LBL2018. Exploratory analysis of prognostic relevance on mutation‐level suggested a potential association of PIK3CA variants c.1624G>A(p.Glu542Lys) and c.1633G>A(p.Glu545Lys) to occurrence of relapse, emphasizing particular relevance of mutation analysis in PI3K‐AKT signaling. Our approach promotes comprehensive and clinically relevant mutational profiling of pediatric T‐LBL.
AbstractList Low incidence and molecular heterogeneity of pediatric T‐cell lymphoblastic lymphoma (T‐LBL) require an international, large‐scale effort to identify novel clinical biomarkers. The ongoing international clinical trial LBL2018 (NCT04043494) represents an ideal opportunity to implement a common analytic approach. Targeted next‐generation sequencing is well‐suited for this purpose; however, selection of relevant target genes for T‐LBL remains subject of ongoing debates. Our group has recently designed and evaluated a first target panel of 80 candidate genes for T‐LBL. The present study aimed at developing a novel optimized gene panel for large‐scale application and to promote an international agreement on a common core panel. Small sequence variants obtained from our former study were systematically analyzed and classified with regards to pathogenic relevance, to prioritize candidate genes. Additional genes were curated from literature and online databases for a more comprehensive analysis of relevant functions and signaling pathways. The new target panel TGP‐T‐LBL entails 84 candidate genes which are key actors in NOTCH, PI3K‐AKT, JAK–STAT, RAS signaling, epigenetic regulation, transcription, DNA repair, cell cycle regulation, and ribosomal function. From our former gene panel, 35 out of 80 candidate genes were selected for the novel panel. Forty‐six out of 84 genes are currently being analyzed in the ongoing international trial LBL2018. Exploratory analysis of prognostic relevance on mutation‐level suggested a potential association of PIK3CA variants c.1624G>A(p.Glu542Lys) and c.1633G>A(p.Glu545Lys) to occurrence of relapse, emphasizing particular relevance of mutation analysis in PI3K‐AKT signaling. Our approach promotes comprehensive and clinically relevant mutational profiling of pediatric T‐LBL.
Low incidence and molecular heterogeneity of pediatric T‐cell lymphoblastic lymphoma (T‐LBL) require an international, large‐scale effort to identify novel clinical biomarkers. The ongoing international clinical trial LBL2018 (NCT04043494) represents an ideal opportunity to implement a common analytic approach. Targeted next‐generation sequencing is well‐suited for this purpose; however, selection of relevant target genes for T‐LBL remains subject of ongoing debates. Our group has recently designed and evaluated a first target panel of 80 candidate genes for T‐LBL. The present study aimed at developing a novel optimized gene panel for large‐scale application and to promote an international agreement on a common core panel. Small sequence variants obtained from our former study were systematically analyzed and classified with regards to pathogenic relevance, to prioritize candidate genes. Additional genes were curated from literature and online databases for a more comprehensive analysis of relevant functions and signaling pathways. The new target panel TGP‐T‐LBL entails 84 candidate genes which are key actors in NOTCH, PI3K‐AKT, JAK–STAT, RAS signaling, epigenetic regulation, transcription, DNA repair, cell cycle regulation, and ribosomal function. From our former gene panel, 35 out of 80 candidate genes were selected for the novel panel. Forty‐six out of 84 genes are currently being analyzed in the ongoing international trial LBL2018. Exploratory analysis of prognostic relevance on mutation‐level suggested a potential association of PIK3CA variants c.1624G>A(p.Glu542Lys) and c.1633G>A(p.Glu545Lys) to occurrence of relapse, emphasizing particular relevance of mutation analysis in PI3K‐AKT signaling. Our approach promotes comprehensive and clinically relevant mutational profiling of pediatric T‐LBL.
Low incidence and molecular heterogeneity of pediatric T-cell lymphoblastic lymphoma (T-LBL) require an international, large-scale effort to identify novel clinical biomarkers. The ongoing international clinical trial LBL2018 (NCT04043494) represents an ideal opportunity to implement a common analytic approach. Targeted next-generation sequencing is well-suited for this purpose; however, selection of relevant target genes for T-LBL remains subject of ongoing debates. Our group has recently designed and evaluated a first target panel of 80 candidate genes for T-LBL. The present study aimed at developing a novel optimized gene panel for large-scale application and to promote an international agreement on a common core panel. Small sequence variants obtained from our former study were systematically analyzed and classified with regards to pathogenic relevance, to prioritize candidate genes. Additional genes were curated from literature and online databases for a more comprehensive analysis of relevant functions and signaling pathways. The new target panel TGP-T-LBL entails 84 candidate genes which are key actors in NOTCH, PI3K-AKT, JAK-STAT, RAS signaling, epigenetic regulation, transcription, DNA repair, cell cycle regulation, and ribosomal function. From our former gene panel, 35 out of 80 candidate genes were selected for the novel panel. Forty-six out of 84 genes are currently being analyzed in the ongoing international trial LBL2018. Exploratory analysis of prognostic relevance on mutation-level suggested a potential association of PIK3CA variants c.1624G>A(p.Glu542Lys) and c.1633G>A(p.Glu545Lys) to occurrence of relapse, emphasizing particular relevance of mutation analysis in PI3K-AKT signaling. Our approach promotes comprehensive and clinically relevant mutational profiling of pediatric T-LBL.Low incidence and molecular heterogeneity of pediatric T-cell lymphoblastic lymphoma (T-LBL) require an international, large-scale effort to identify novel clinical biomarkers. The ongoing international clinical trial LBL2018 (NCT04043494) represents an ideal opportunity to implement a common analytic approach. Targeted next-generation sequencing is well-suited for this purpose; however, selection of relevant target genes for T-LBL remains subject of ongoing debates. Our group has recently designed and evaluated a first target panel of 80 candidate genes for T-LBL. The present study aimed at developing a novel optimized gene panel for large-scale application and to promote an international agreement on a common core panel. Small sequence variants obtained from our former study were systematically analyzed and classified with regards to pathogenic relevance, to prioritize candidate genes. Additional genes were curated from literature and online databases for a more comprehensive analysis of relevant functions and signaling pathways. The new target panel TGP-T-LBL entails 84 candidate genes which are key actors in NOTCH, PI3K-AKT, JAK-STAT, RAS signaling, epigenetic regulation, transcription, DNA repair, cell cycle regulation, and ribosomal function. From our former gene panel, 35 out of 80 candidate genes were selected for the novel panel. Forty-six out of 84 genes are currently being analyzed in the ongoing international trial LBL2018. Exploratory analysis of prognostic relevance on mutation-level suggested a potential association of PIK3CA variants c.1624G>A(p.Glu542Lys) and c.1633G>A(p.Glu545Lys) to occurrence of relapse, emphasizing particular relevance of mutation analysis in PI3K-AKT signaling. Our approach promotes comprehensive and clinically relevant mutational profiling of pediatric T-LBL.
Author Khanam, Tasneem
Ruether, Charlotte
Burkhardt, Birgit
Michgehl, Ulf
Wuensch, Christian
Dugas, Martin
Trautmann, Marcel
Sandmann, Sarah
Randau, Gerrit
Hartmann, Wolfgang
Author_xml – sequence: 1
  givenname: Charlotte
  orcidid: 0000-0002-6356-5936
  surname: Ruether
  fullname: Ruether, Charlotte
  organization: University Hospital Muenster
– sequence: 2
  givenname: Christian
  orcidid: 0000-0003-4367-3857
  surname: Wuensch
  fullname: Wuensch, Christian
  organization: Muenster University
– sequence: 3
  givenname: Gerrit
  surname: Randau
  fullname: Randau, Gerrit
  organization: University Hospital Muenster
– sequence: 4
  givenname: Ulf
  surname: Michgehl
  fullname: Michgehl, Ulf
  organization: University Hospital Muenster
– sequence: 5
  givenname: Marcel
  orcidid: 0000-0002-5842-1196
  surname: Trautmann
  fullname: Trautmann, Marcel
  organization: Gerhard‐Domagk‐Institute of Pathology, University Hospital Muenster
– sequence: 6
  givenname: Wolfgang
  orcidid: 0000-0002-7609-5021
  surname: Hartmann
  fullname: Hartmann, Wolfgang
  organization: Gerhard‐Domagk‐Institute of Pathology, University Hospital Muenster
– sequence: 7
  givenname: Sarah
  orcidid: 0000-0002-5011-0641
  surname: Sandmann
  fullname: Sandmann, Sarah
  organization: Muenster University
– sequence: 8
  givenname: Martin
  orcidid: 0000-0001-9740-0788
  surname: Dugas
  fullname: Dugas, Martin
  organization: Muenster University
– sequence: 9
  givenname: Tasneem
  surname: Khanam
  fullname: Khanam, Tasneem
  organization: University Hospital Muenster
– sequence: 10
  givenname: Birgit
  orcidid: 0000-0002-1151-829X
  surname: Burkhardt
  fullname: Burkhardt, Birgit
  email: birgit.burkhardt@ukmuenster.de
  organization: University Hospital Muenster
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35278000$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1u1DAUhS1U1D-64AWQJTawmNaO47GzrKalIFWwmX1049wEV4kdbKcwrPoISLxhn6SeTmFRCVY-1_rOlY_PEdlz3iEhrzk75YwVZ70xp4VgQr0gh5xVelEUy3Jvq0uZtVQH5CjGG8bYUlRynxwIWSidx0Py-wKj7R31HQWaIPSYsKUOf6T7u189OgyQrHf04vM5jfhtRmes6-kEDgfa-UAnbC2kYA1dZ4fBYaDDZpy--maAmPL1bhrzdk9nF-A2GxvrB99vKLiW-inZ0f5EmgJCGtGlV-RlB0PEk6fzmKw_XK5XHxfXX64-rc6vF0ZorRZdK0yjSxAVYsd5kzNnVSkB2PJCgoZGVwoMAy1BlKrrZNkp4AZQVksQx-Tdbu0UfA4WUz3auA2Qs_k51sVSaFVqVoiMvn2G3vg5uPy4TClZlhXjRabePFFzM2JbT8GOEDb1n9_OwPsdYIKPMWD3F-Gs3jZZ5ybrxyYze_aMNTY9dpEC2OF_ju92wM2_V9dXq9XO8QB_JbMl
CitedBy_id crossref_primary_10_1002_pbc_29926
crossref_primary_10_1016_j_beha_2023_101449
Cites_doi 10.1182/blood-2013-11-539726
10.1055/s-0039-1688446
10.1038/nature07943
10.1016/j.bbmt.2009.09.021
10.1158/1078-0432.CCR-09-1165
10.1186/s12885-015-1977-3
10.1038/nmeth.2890
10.3109/08880018.2013.789574
10.1038/nature25480
10.3324/haematol.2016.147116
10.1093/nar/gky1015
10.1200/JCO.2012.48.5292
10.1016/j.jbior.2019.100647
10.1101/cshperspect.a035246
10.1200/JCO.2011.39.7661
10.1186/s40246-016-0061-7
10.1038/bcj.2017.3
10.1111/j.1365-2141.2005.05735.x
10.1371/journal.pone.0046688
10.1038/s41586-020-2308-7
10.1373/clinchem.2014.231100
10.1038/s41375-020-0862-5
10.1200/PO.17.00011
10.1186/1479-7364-8-11
10.1038/s41568-018-0060-1
10.1182/blood-2012-12-474148
10.1182/blood-2018-02-832253
10.1111/cas.13730
10.1007/s00432-018-2763-9
10.3324/haematol.2012.073585
10.1073/pnas.0712169105
10.1038/leu.2015.203
10.1038/nmeth0410-248
10.1111/j.1365-2141.2008.07320.x
10.1016/j.csbj.2019.10.004
10.1200/JCO.2008.19.3367
10.1038/nbt.3391
10.1111/bjh.15793
10.1182/blood.2020005381
10.1111/bjh.14017
10.1038/ng.3909
10.1016/j.ejmg.2015.12.014
10.1146/annurev-pharmtox-010716-105106
10.1158/1078-0432.CCR-07-0266
10.3389/fonc.2020.00273
10.1016/j.jmoldx.2016.10.002
10.1038/s41375-019-0473-1
10.3390/cancers11122030
10.1200/JCO.1995.13.2.359
10.1080/10428190701824551
10.1111/bjh.13105
10.1038/nprot.2009.86
10.3324/haematol.2015.129692
10.1016/j.ejca.2016.06.009
10.1038/nature15393
10.1038/sj.leu.2404275
10.1111/cas.13837
10.1007/s11899-018-0455-9
10.21873/anticanres.13328
10.3324/haematol.2019.220863
10.1038/gim.2015.166
10.1111/j.1365-2141.2009.08006.x
10.1182/asheducation-2016.1.580
10.1093/bioinformatics/bty518
10.1002/gcc.22416
10.1093/nar/gkv1222
10.1038/gim.2015.30
10.1182/bloodadvances.2020001822
ContentType Journal Article
Copyright 2022 The Authors. published by Wiley Periodicals LLC.
2022 The Authors. Genes, Chromosomes and Cancer published by Wiley Periodicals LLC.
2022. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2022 The Authors. published by Wiley Periodicals LLC.
– notice: 2022 The Authors. Genes, Chromosomes and Cancer published by Wiley Periodicals LLC.
– notice: 2022. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7TM
7TO
8FD
FR3
H94
K9.
P64
RC3
7X8
DOI 10.1002/gcc.23037
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Genetics Abstracts
Oncogenes and Growth Factors Abstracts
Technology Research Database
Nucleic Acids Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Calcium & Calcified Tissue Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList Genetics Abstracts
MEDLINE
CrossRef

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1098-2264
EndPage 470
ExternalDocumentID 35278000
10_1002_gcc_23037
GCC23037
Genre article
Journal Article
GrantInformation_xml – fundername: Deutsche Kinderkrebsstiftung
  funderid: 2016.24; 2018.21
– fundername: Deutsche Krebshilfe
  funderid: 111347
– fundername: José Carreras Leukämie‐Stiftung
  funderid: 05 PSG/2017
– fundername: José Carreras Leukämie-Stiftung
  grantid: 05 PSG/2017
– fundername: Deutsche Krebshilfe
  grantid: 111347
– fundername: Deutsche Kinderkrebsstiftung
  grantid: 2016.24
– fundername: Deutsche Kinderkrebsstiftung
  grantid: 2018.21
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
24P
31~
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEFU
ABEML
ABIJN
ABJNI
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GLUZI
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M6P
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
UB1
V2E
V8K
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WWO
WXI
WXSBR
XG1
XPP
XV2
ZGI
ZZTAW
~IA
~WT
AAMMB
AAYXX
AEFGJ
AEYWJ
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
AIQQE
CITATION
O8X
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7TM
7TO
8FD
FR3
H94
K9.
P64
RC3
7X8
ID FETCH-LOGICAL-c3887-fd3cb84a39eef11b2649ee973aed125a8ab897ac0a85a347ff54f7a1cae596a3
IEDL.DBID 24P
ISICitedReferencesCount 2
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000771966500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1045-2257
1098-2264
IngestDate Fri Jul 11 10:45:51 EDT 2025
Sat Nov 29 14:53:34 EST 2025
Wed Feb 19 02:26:32 EST 2025
Sat Nov 29 02:51:30 EST 2025
Tue Nov 18 21:09:48 EST 2025
Wed Jan 22 16:23:53 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords variant classification
clinical trials
targeted gene panel
pediatric oncology
lymphoblastic lymphoma
Language English
License Attribution-NonCommercial-NoDerivs
2022 The Authors. Genes, Chromosomes and Cancer published by Wiley Periodicals LLC.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3887-fd3cb84a39eef11b2649ee973aed125a8ab897ac0a85a347ff54f7a1cae596a3
Notes Funding information
Tasneem Khanam and Birgit Burkhardt contributed equally.
Deutsche Kinderkrebsstiftung, Grant/Award Numbers: 2016.24, 2018.21; Deutsche Krebshilfe, Grant/Award Number: 111347; José Carreras Leukämie‐Stiftung, Grant/Award Number: 05 PSG/2017
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-6356-5936
0000-0002-7609-5021
0000-0001-9740-0788
0000-0002-5842-1196
0000-0003-4367-3857
0000-0002-1151-829X
0000-0002-5011-0641
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fgcc.23037
PMID 35278000
PQID 2675449012
PQPubID 866394
PageCount 12
ParticipantIDs proquest_miscellaneous_2638748023
proquest_journals_2675449012
pubmed_primary_35278000
crossref_primary_10_1002_gcc_23037
crossref_citationtrail_10_1002_gcc_23037
wiley_primary_10_1002_gcc_23037_GCC23037
PublicationCentury 2000
PublicationDate August 2022
2022-08-00
2022-Aug
20220801
PublicationDateYYYYMMDD 2022-08-01
PublicationDate_xml – month: 08
  year: 2022
  text: August 2022
PublicationDecade 2020
PublicationPlace Hoboken, USA
PublicationPlace_xml – name: Hoboken, USA
– name: United States
– name: Hoboken
PublicationTitle Genes chromosomes & cancer
PublicationTitleAlternate Genes Chromosomes Cancer
PublicationYear 2022
Publisher John Wiley & Sons, Inc
Wiley Subscription Services, Inc
Publisher_xml – name: John Wiley & Sons, Inc
– name: Wiley Subscription Services, Inc
References 2017; 7
2010; 16
2005; 131
2019; 11
2010; 149
2017; 49
2015; 100
2019; 17
2000; 95
2016; 101
2016; 30
2016; 2016
2008; 105
2013; 121
2020; 10
2008; 143
2016; 34
2021; 35
2018; 132
2020; 4
2006; 20
2013; 98
2018; 34
2014; 8
2016; 49
2010; 7
2014; 11
2009; 15
2014; 123
2019; 110
2016; 44
2015; 15
2018; 144
2015; 17
2017; 2017
2020; 581
2019; 74
2015; 168
2019; 33
1995; 13
2016; 10
2019; 39
2020; 105
2015; 526
2018; 109
2016; 18
2019; 185
2016; 59
2009; 27
2007; 13
2012; 30
2009; 458
2018; 18
2021; 137
2015; 61
2020
2019; 45
2008; 49
2018; 555
2013; 31
2013; 30
2019; 47
2017; 56
2016; 65
2017; 19
2009; 4
2012; 7
2016; 173
2018; 58
2018; 13
e_1_2_9_75_1
e_1_2_9_31_1
e_1_2_9_52_1
e_1_2_9_50_1
e_1_2_9_73_1
e_1_2_9_10_1
e_1_2_9_35_1
e_1_2_9_56_1
e_1_2_9_77_1
e_1_2_9_12_1
e_1_2_9_33_1
e_1_2_9_54_1
R Core Team (e_1_2_9_57_1) 2020
e_1_2_9_71_1
Reiter A (e_1_2_9_4_1) 2000; 95
e_1_2_9_14_1
e_1_2_9_39_1
e_1_2_9_16_1
e_1_2_9_37_1
e_1_2_9_58_1
e_1_2_9_18_1
e_1_2_9_41_1
e_1_2_9_64_1
e_1_2_9_20_1
e_1_2_9_62_1
e_1_2_9_22_1
e_1_2_9_45_1
e_1_2_9_68_1
e_1_2_9_24_1
e_1_2_9_43_1
e_1_2_9_66_1
e_1_2_9_8_1
e_1_2_9_6_1
e_1_2_9_60_1
e_1_2_9_2_1
Griffith M (e_1_2_9_28_1) 2016; 49
e_1_2_9_49_1
e_1_2_9_47_1
e_1_2_9_30_1
e_1_2_9_53_1
e_1_2_9_74_1
e_1_2_9_51_1
e_1_2_9_72_1
e_1_2_9_11_1
e_1_2_9_34_1
e_1_2_9_13_1
e_1_2_9_32_1
e_1_2_9_55_1
e_1_2_9_76_1
e_1_2_9_70_1
e_1_2_9_15_1
e_1_2_9_38_1
e_1_2_9_17_1
e_1_2_9_36_1
e_1_2_9_59_1
e_1_2_9_19_1
e_1_2_9_42_1
e_1_2_9_63_1
e_1_2_9_40_1
e_1_2_9_61_1
e_1_2_9_21_1
e_1_2_9_46_1
e_1_2_9_67_1
e_1_2_9_23_1
e_1_2_9_44_1
e_1_2_9_65_1
e_1_2_9_7_1
e_1_2_9_5_1
e_1_2_9_3_1
e_1_2_9_9_1
Chakravarty D (e_1_2_9_26_1) 2017; 2017
e_1_2_9_25_1
e_1_2_9_27_1
e_1_2_9_48_1
e_1_2_9_69_1
e_1_2_9_29_1
References_xml – volume: 30
  start-page: 970
  year: 2016
  end-page: 973
  article-title: Proposal of a genetic classifier for risk group stratification in pediatric T‐cell lymphoblastic lymphoma reveals differences from adult T‐cell lymphoblastic leukemia
  publication-title: Leukemia
– volume: 44
  start-page: D862
  year: 2016
  end-page: D868
  article-title: ClinVar: public archive of interpretations of clinically relevant variants
  publication-title: Nucleic Acids Res
– volume: 61
  start-page: 544
  year: 2015
  end-page: 553
  article-title: Clinical actionability enhanced through deep targeted sequencing of solid tumors
  publication-title: Clin Chem
– volume: 7
  year: 2017
  article-title: Identification of a genetically defined ultra‐high‐risk group in relapsed pediatric T‐lymphoblastic leukemia
  publication-title: Blood Cancer J
– volume: 49
  start-page: 451
  year: 2008
  end-page: 461
  article-title: Pediatric precursor T lymphoblastic leukemia and lymphoblastic lymphoma: differences in the common regions with loss of heterozygosity at chromosome 6q and their prognostic impact
  publication-title: Leuk Lymphoma.
– volume: 34
  start-page: 155
  year: 2016
  end-page: 163
  article-title: Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity
  publication-title: Nat Biotechnol
– volume: 58
  start-page: 187
  year: 2018
  end-page: 207
  article-title: Targeting epigenetics in cancer
  publication-title: Annu Rev Pharmacol Toxicol
– volume: 10
  start-page: a035246
  year: 2020
  article-title: The genetics and mechanisms of T‐cell acute lymphoblastic leukemia
  publication-title: Cold Spring Harb Perspect Med
– volume: 173
  start-page: 545
  year: 2016
  end-page: 559
  article-title: Current status and future directions of T‐lymphoblastic lymphoma in children and adolescents
  publication-title: Br J Haematol
– volume: 13
  start-page: 265
  year: 2018
  end-page: 274
  article-title: Recent advances in the biology and treatment of T cell acute lymphoblastic leukemia
  publication-title: Curr Hematol Malig Rep
– volume: 144
  start-page: 2495
  year: 2018
  end-page: 2513
  article-title: Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings
  publication-title: J Cancer Res Clin Oncol
– volume: 137
  start-page: 2347
  year: 2021
  end-page: 2359
  article-title: Integrative genomic analysis of pediatric T‐ cell lymphoblastic lymphoma reveals candidates of clinical significance
  publication-title: Blood
– volume: 105
  start-page: 2652
  year: 2008
  end-page: 2657
  article-title: Helical domain and kinase domain mutations in p110α of phosphatidylinositol 3‐kinase induce gain of function by different mechanisms
  publication-title: Proc Natl Acad Sci U S A.
– volume: 49
  year: 2016
  article-title: CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer
  publication-title: bioRxiv
– volume: 10
  start-page: 273
  year: 2020
  article-title: The physiopathology of T‐cell acute lymphoblastic leukemia: focus on molecular aspects
  publication-title: Front Oncol
– volume: 110
  start-page: 6
  year: 2019
  end-page: 15
  article-title: Next generation sequencing‐based gene panel tests for the management of solid tumors
  publication-title: Cancer Sci
– volume: 34
  start-page: 4205
  year: 2018
  end-page: 4212
  article-title: appreci8: a pipeline for precise variant calling integrating 8 tools
  publication-title: Bioinformatics
– volume: 15
  start-page: 6956
  year: 2009
  end-page: 6962
  article-title: PIK3CA mutations predict local recurrences in rectal cancer patients
  publication-title: Clin Cancer Res
– volume: 30
  start-page: 1966
  year: 2012
  end-page: 1973
  article-title: Clinical impact of NOTCH1 and/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T‐cell lymphoblastic lymphoma
  publication-title: J Clin Oncol
– volume: 100
  start-page: 1442
  year: 2015
  end-page: 1450
  article-title: Pediatric T‐cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation
  publication-title: Haematologica
– volume: 8
  start-page: 11
  year: 2014
  article-title: Ranking non‐synonymous single nucleotide polymorphisms based on disease concepts
  publication-title: Hum Genomics
– volume: 143
  start-page: 261
  year: 2008
  end-page: 267
  article-title: Shortened intensified multi‐agent chemotherapy and non‐cross resistant maintenance therapy for advanced lymphoblastic lymphoma in children and adolescents: report from the Children's Oncology Group
  publication-title: Br J Haematol
– volume: 185
  start-page: 1158
  year: 2019
  end-page: 1170
  article-title: Lymphoblastic lymphoma in children and adolescents: review of current challenges and future opportunities
  publication-title: Br J Haematol
– volume: 7
  year: 2012
  article-title: Predicting the functional effect of amino acid substitutions and indels
  publication-title: PLoS One
– volume: 39
  start-page: 2145
  year: 2019
  end-page: 2154
  article-title: Exon 9 mutation of PIK3CA associated with poor survival in patients with Epstein–Barr virus‐associated gastric cancer
  publication-title: Anticancer Res
– volume: 95
  start-page: 416
  year: 2000
  end-page: 421
  article-title: Intensive ALL‐type therapy without local radiotherapy provides a 90% event‐free survival for children with T‐cell lymphoblastic lymphoma: a BFM group report
  publication-title: Blood
– volume: 7
  start-page: 248
  year: 2010
  end-page: 249
  article-title: A method and server for predicting damaging missense mutations
  publication-title: Nat Methods.
– volume: 131
  start-page: 39
  year: 2005
  end-page: 49
  article-title: The impact of age and gender on biology, clinical features and treatment outcome of non‐Hodgkin lymphoma in childhood and adolescence
  publication-title: Br J Haematol
– volume: 11
  start-page: 361
  year: 2014
  end-page: 362
  article-title: MutationTaster2: mutation prediction for the deep‐sequencing age
  publication-title: Nat Methods
– volume: 4
  start-page: 1073
  year: 2009
  end-page: 1082
  article-title: Predicting the effects of coding non‐synonymous variants on protein function using the SIFT algorithm
  publication-title: Nat Protoc
– volume: 123
  start-page: 2139
  year: 2014
  end-page: 2147
  article-title: Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia
  publication-title: Blood.
– volume: 2016
  start-page: 580
  year: 2016
  end-page: 588
  article-title: T‐cell acute lymphoblastic leukemia
  publication-title: Hematology
– volume: 27
  start-page: 3363
  year: 2009
  end-page: 3369
  article-title: Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the Berlin‐Frankfurt‐Muenster group
  publication-title: J Clin Oncol
– volume: 10
  start-page: 4
  year: 2016
  article-title: The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies
  publication-title: Hum Genomics
– volume: 35
  start-page: 639
  year: 2021
  end-page: 643
  article-title: Reconstructing clonal evolution in relapsed and non‐relapsed Burkitt lymphoma
  publication-title: Leukemia
– volume: 47
  start-page: D941
  year: 2019
  end-page: D947
  article-title: COSMIC: the catalogue of somatic mutations in cancer
  publication-title: Nucleic Acids Res
– volume: 581
  start-page: 434
  year: 2020
  end-page: 443
  article-title: The mutational constraint spectrum quantified from variation in 141 456 humans
  publication-title: Nature
– volume: 101
  start-page: 1581
  year: 2016
  end-page: 1591
  article-title: Non‐Hodgkin lymphoma and pre‐existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescents
  publication-title: Haematologica
– volume: 18
  start-page: 696
  year: 2018
  end-page: 705
  article-title: The COSMIC cancer gene census: describing genetic dysfunction across all human cancers
  publication-title: Nat Rev Cancer
– volume: 105
  start-page: e107
  year: 2020
  end-page: e110
  article-title: Genomic and outcome analysis of adult T‐cell lymphoblastic lymphoma
  publication-title: Haematologica
– volume: 33
  start-page: 2867
  year: 2019
  end-page: 2883
  article-title: Molecular heterogeneity in peripheral T‐cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling
  publication-title: Leukemia
– volume: 45
  start-page: 661
  year: 2019
  end-page: 673
  article-title: Next‐generation sequencing and emerging technologies
  publication-title: Semin Thromb Hemost
– volume: 49
  start-page: 1211
  year: 2017
  end-page: 1218
  article-title: The genomic landscape of pediatric and young adult T‐lineage acute lymphoblastic leukemia
  publication-title: Nat Genet
– volume: 31
  start-page: 4333
  year: 2013
  end-page: 4342
  article-title: Toward a NOTCH1/FBXW7/RAS/PTEN‐based oncogenetic risk classification of adult T‐cell acute lymphoblastic leukemia: a group for research in adult acute lymphoblastic leukemia study
  publication-title: J Clin Oncol
– volume: 56
  start-page: 89
  year: 2017
  end-page: 116
  article-title: Pediatric T‐cell acute lymphoblastic leukemia
  publication-title: Genes Chromosomes Cancer
– volume: 16
  start-page: 223
  year: 2010
  end-page: 230
  article-title: Hematopoietic stem cell transplantation for refractory or recurrent non‐Hodgkin lymphoma in children and adolescents
  publication-title: Biol Blood Marrow Transplant
– volume: 149
  start-page: 653
  year: 2010
  end-page: 668
  article-title: Paediatric lymphoblastic T‐cell leukaemia and lymphoma: one or two diseases?
  publication-title: Br J Haematol
– volume: 13
  start-page: 359
  year: 1995
  end-page: 372
  article-title: Non‐Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage ‐ a report of the Berlin‐Frankfurt‐Münster group
  publication-title: J Clin Oncol
– volume: 168
  start-page: 308
  year: 2015
  end-page: 313
  article-title: Whole exome sequencing hints at a unique mutational profile of paediatric T‐cell lymphoblastic lymphoma
  publication-title: Br J Haematol
– volume: 19
  start-page: 4
  year: 2017
  end-page: 23
  article-title: Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists
  publication-title: J Mol Diagn
– volume: 30
  start-page: 484
  year: 2013
  end-page: 508
  article-title: Lymphoblastic lymphoma in childhood and adolescence
  publication-title: Pediatr Hematol Oncol
– volume: 121
  start-page: 3153
  year: 2013
  end-page: 3160
  article-title: Incidence and prognostic relevance of genetic variations in T‐cell lymphoblastic lymphoma in childhood and adolescence
  publication-title: Blood
– volume: 526
  start-page: 68
  year: 2015
  end-page: 74
  article-title: A global reference for human genetic variation
  publication-title: Nature
– volume: 98
  start-page: 928
  year: 2013
  end-page: 936
  article-title: NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM‐treated children with precursor T‐cell acute lymphoblastic leukemia
  publication-title: Haematologica.
– volume: 65
  start-page: 91
  year: 2016
  end-page: 101
  article-title: Next‐generation personalised medicine for high‐risk paediatric cancer patients – The INFORM pilot study
  publication-title: Eur J Cancer
– volume: 18
  start-page: 823
  year: 2016
  end-page: 832
  article-title: Pathogenic and likely pathogenic variant prevalence among the first 10 000 patients referred for next‐generation cancer panel testing
  publication-title: Genet Med
– volume: 17
  start-page: 1348
  year: 2019
  end-page: 1359
  article-title: Applications and analysis of targeted genomic sequencing in cancer studies
  publication-title: Comput Struct Biotechnol J
– volume: 2017
  start-page: 1
  year: 2017
  end-page: 16
  article-title: OncoKB: a precision oncology knowledge base
  publication-title: JCO Precis Oncol
– volume: 4
  start-page: 3466
  year: 2020
  end-page: 3473
  article-title: T‐cell lymphoblastic lymphoma and leukemia: different diseases from a common premalignant progenitor?
  publication-title: Blood Adv
– volume: 15
  start-page: 986
  year: 2015
  article-title: High EGFR protein expression and exon 9 PIK3CA mutations are independent prognostic factors in triple negative breast cancers
  publication-title: BMC Cancer
– volume: 20
  start-page: 1422
  year: 2006
  end-page: 1429
  article-title: Loss of heterozygosity on chromosome 6q14‐q24 is associated with poor outcome in children and adolescents with T‐cell lymphoblastic lymphoma
  publication-title: Leukemia
– year: 2020
– volume: 59
  start-page: 133
  year: 2016
  end-page: 142
  article-title: Acute lymphoblastic leukemia and lymphoma in the context of constitutional mismatch repair deficiency syndrome
  publication-title: Eur J Med Genet
– volume: 13
  start-page: 6064
  year: 2007
  end-page: 6069
  article-title: Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas
  publication-title: Clin Cancer Res
– volume: 555
  start-page: 321
  year: 2018
  end-page: 327
  article-title: The landscape of genomic alterations across childhood cancers
  publication-title: Nature
– volume: 74
  start-page: 100647
  year: 2019
  article-title: Multi‐omic approaches to improve outcome for T‐cell acute lymphoblastic leukemia patients
  publication-title: Adv Biol Regul
– volume: 11
  start-page: 2030
  year: 2019
  article-title: Standardization of somatic variant classifications in solid and haematological tumours by a two‐level approach of biological and clinical classes: an initiative of the Belgian ComPerMed expert panel
  publication-title: Cancers
– volume: 132
  start-page: 948
  year: 2018
  end-page: 961
  article-title: Integrative genomic analysis reveals cancer‐associated mutations at diagnosis of CML in patients with high‐risk disease
  publication-title: Blood
– volume: 17
  start-page: 405
  year: 2015
  end-page: 424
  article-title: Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
  publication-title: Genet Med
– volume: 109
  start-page: 2980
  year: 2018
  end-page: 2985
  article-title: Clinical practice guidance for next‐generation sequencing in cancer diagnosis and treatment (Edition 1.0)
  publication-title: Cancer Sci
– volume: 458
  start-page: 719
  year: 2009
  end-page: 724
  article-title: The cancer genome
  publication-title: Nature
– ident: e_1_2_9_19_1
  doi: 10.1182/blood-2013-11-539726
– ident: e_1_2_9_72_1
  doi: 10.1055/s-0039-1688446
– ident: e_1_2_9_56_1
– ident: e_1_2_9_76_1
  doi: 10.1038/nature07943
– ident: e_1_2_9_7_1
  doi: 10.1016/j.bbmt.2009.09.021
– ident: e_1_2_9_70_1
  doi: 10.1158/1078-0432.CCR-09-1165
– ident: e_1_2_9_67_1
  doi: 10.1186/s12885-015-1977-3
– ident: e_1_2_9_32_1
  doi: 10.1038/nmeth.2890
– volume-title: R: A Language and Environment for Statistical Computing [Software]
  year: 2020
  ident: e_1_2_9_57_1
– ident: e_1_2_9_6_1
  doi: 10.3109/08880018.2013.789574
– ident: e_1_2_9_50_1
  doi: 10.1038/nature25480
– ident: e_1_2_9_62_1
  doi: 10.3324/haematol.2016.147116
– ident: e_1_2_9_24_1
  doi: 10.1093/nar/gky1015
– ident: e_1_2_9_65_1
  doi: 10.1200/JCO.2012.48.5292
– ident: e_1_2_9_42_1
  doi: 10.1016/j.jbior.2019.100647
– ident: e_1_2_9_44_1
  doi: 10.1101/cshperspect.a035246
– ident: e_1_2_9_11_1
  doi: 10.1200/JCO.2011.39.7661
– ident: e_1_2_9_27_1
  doi: 10.1186/s40246-016-0061-7
– ident: e_1_2_9_21_1
  doi: 10.1038/bcj.2017.3
– ident: e_1_2_9_3_1
  doi: 10.1111/j.1365-2141.2005.05735.x
– ident: e_1_2_9_30_1
  doi: 10.1371/journal.pone.0046688
– ident: e_1_2_9_36_1
  doi: 10.1038/s41586-020-2308-7
– ident: e_1_2_9_51_1
  doi: 10.1373/clinchem.2014.231100
– ident: e_1_2_9_77_1
  doi: 10.1038/s41375-020-0862-5
– volume: 2017
  start-page: 1
  year: 2017
  ident: e_1_2_9_26_1
  article-title: OncoKB: a precision oncology knowledge base
  publication-title: JCO Precis Oncol
  doi: 10.1200/PO.17.00011
– ident: e_1_2_9_33_1
  doi: 10.1186/1479-7364-8-11
– ident: e_1_2_9_59_1
  doi: 10.1038/s41568-018-0060-1
– ident: e_1_2_9_12_1
  doi: 10.1182/blood-2012-12-474148
– ident: e_1_2_9_64_1
  doi: 10.1182/blood-2018-02-832253
– ident: e_1_2_9_52_1
  doi: 10.1111/cas.13730
– ident: e_1_2_9_75_1
  doi: 10.1007/s00432-018-2763-9
– ident: e_1_2_9_66_1
  doi: 10.3324/haematol.2012.073585
– ident: e_1_2_9_71_1
  doi: 10.1073/pnas.0712169105
– ident: e_1_2_9_13_1
  doi: 10.1038/leu.2015.203
– ident: e_1_2_9_34_1
  doi: 10.1038/nmeth0410-248
– ident: e_1_2_9_5_1
  doi: 10.1111/j.1365-2141.2008.07320.x
– ident: e_1_2_9_18_1
  doi: 10.1016/j.csbj.2019.10.004
– ident: e_1_2_9_8_1
  doi: 10.1200/JCO.2008.19.3367
– ident: e_1_2_9_25_1
  doi: 10.1038/nbt.3391
– volume: 95
  start-page: 416
  year: 2000
  ident: e_1_2_9_4_1
  article-title: Intensive ALL‐type therapy without local radiotherapy provides a 90% event‐free survival for children with T‐cell lymphoblastic lymphoma: a BFM group report
  publication-title: Blood
– ident: e_1_2_9_10_1
  doi: 10.1111/bjh.15793
– ident: e_1_2_9_14_1
  doi: 10.1182/blood.2020005381
– ident: e_1_2_9_9_1
  doi: 10.1111/bjh.14017
– ident: e_1_2_9_46_1
  doi: 10.1038/ng.3909
– ident: e_1_2_9_61_1
  doi: 10.1016/j.ejmg.2015.12.014
– ident: e_1_2_9_54_1
– ident: e_1_2_9_60_1
  doi: 10.1146/annurev-pharmtox-010716-105106
– ident: e_1_2_9_68_1
  doi: 10.1158/1078-0432.CCR-07-0266
– ident: e_1_2_9_45_1
  doi: 10.3389/fonc.2020.00273
– ident: e_1_2_9_58_1
– ident: e_1_2_9_23_1
  doi: 10.1016/j.jmoldx.2016.10.002
– ident: e_1_2_9_63_1
  doi: 10.1038/s41375-019-0473-1
– ident: e_1_2_9_22_1
  doi: 10.3390/cancers11122030
– ident: e_1_2_9_2_1
  doi: 10.1200/JCO.1995.13.2.359
– ident: e_1_2_9_15_1
  doi: 10.1080/10428190701824551
– ident: e_1_2_9_47_1
  doi: 10.1111/bjh.13105
– ident: e_1_2_9_31_1
  doi: 10.1038/nprot.2009.86
– ident: e_1_2_9_20_1
  doi: 10.3324/haematol.2015.129692
– ident: e_1_2_9_49_1
  doi: 10.1016/j.ejca.2016.06.009
– ident: e_1_2_9_35_1
  doi: 10.1038/nature15393
– ident: e_1_2_9_16_1
  doi: 10.1038/sj.leu.2404275
– ident: e_1_2_9_17_1
  doi: 10.1111/cas.13837
– ident: e_1_2_9_43_1
  doi: 10.1007/s11899-018-0455-9
– ident: e_1_2_9_69_1
  doi: 10.21873/anticanres.13328
– ident: e_1_2_9_48_1
  doi: 10.3324/haematol.2019.220863
– ident: e_1_2_9_74_1
  doi: 10.1038/gim.2015.166
– ident: e_1_2_9_37_1
– ident: e_1_2_9_39_1
  doi: 10.1111/j.1365-2141.2009.08006.x
– ident: e_1_2_9_55_1
  doi: 10.1182/asheducation-2016.1.580
– ident: e_1_2_9_38_1
  doi: 10.1093/bioinformatics/bty518
– ident: e_1_2_9_41_1
  doi: 10.1002/gcc.22416
– ident: e_1_2_9_29_1
  doi: 10.1093/nar/gkv1222
– ident: e_1_2_9_73_1
  doi: 10.1038/gim.2015.30
– ident: e_1_2_9_40_1
  doi: 10.1182/bloodadvances.2020001822
– volume: 49
  start-page: 072892
  year: 2016
  ident: e_1_2_9_28_1
  article-title: CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer
  publication-title: bioRxiv
– ident: e_1_2_9_53_1
SSID ssj0006395
Score 2.3791168
Snippet Low incidence and molecular heterogeneity of pediatric T‐cell lymphoblastic lymphoma (T‐LBL) require an international, large‐scale effort to identify novel...
Low incidence and molecular heterogeneity of pediatric T-cell lymphoblastic lymphoma (T-LBL) require an international, large-scale effort to identify novel...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 459
SubjectTerms 1-Phosphatidylinositol 3-kinase
AKT protein
Biology
Cell cycle
Child
clinical trials
Deoxyribonucleic acid
DNA
DNA repair
DNA sequencing
Epigenesis, Genetic
Epigenetics
Gene regulation
Genes
High-Throughput Nucleotide Sequencing
Humans
lymphoblastic lymphoma
Lymphoma
Lymphoma, T-Cell - genetics
Mutation
Neoplasm Recurrence, Local - genetics
pediatric oncology
Pediatrics
Phosphatidylinositol 3-Kinases - genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - genetics
Proto-Oncogene Proteins c-akt - genetics
Sequence Analysis, DNA
T-Lymphocytes
targeted gene panel
variant classification
Title Design of a targeted next‐generation DNA sequencing panel for pediatric T‐cell lymphoblastic lymphoma to unravel biology and optimize treatment
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fgcc.23037
https://www.ncbi.nlm.nih.gov/pubmed/35278000
https://www.proquest.com/docview/2675449012
https://www.proquest.com/docview/2638748023
Volume 61
WOSCitedRecordID wos000771966500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library Full Collection 2020
  customDbUrl:
  eissn: 1098-2264
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0006395
  issn: 1045-2257
  databaseCode: DRFUL
  dateStart: 19960101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB6VFhAXHqXQLaUaEAcuUZPYWTvqqdpl4VBWFVqkvUV-paq0TapuF6k98RMq9R_ySxg7D1QBEhKXyFHGsWXPjL_E428A3hlHH12G8Yg7mUVc2DJSVplI2yQu81grrQOJ65GYTuV8nh-vwUF3Fqbhh-h_uHnLCP7aG7jSy_1fpKEnxvgoZibuwUaSMOnzNqT8uHfDtPRmDRVBFpHSio5WKE73-6p3F6PfEOZdwBpWnMmT_-rrU3jcAk08bDTjGay5ahMeNKknrzbh4ed2U_053I5DFAfWJSpsIsOdxYq89o_vNyeBltrPHo6nh9hGXtN6h-RG3AIJ8-J5l-4DZ1TDbwXg4oq0pNYEzan59u6M3l7jqvIJjxbYsj-hqizW5LfOTq8d9mHvWzCbfJiNPkVtrobIMO-nSsuMllyx3LkySTThLCrlgilnCUMpqbTMhTKxkpliXJRlxkuhEqNclg8VewHrVV25bUBPX8NEZnMtPdxMJGFI7YaWkJLlhJcG8L6bs8K0POY-ncaiaBiY04JGuwijPYC3veh5Q97xJ6HdbuKL1n6XRTr0xICEldIBvOkfk-X5MaThrVdehknBPYHeAF42CtO3QrBWEBSPqbNBL_7efPFxNAqFnX8XfQWPUn8KI8Qh7sL65cXKvYb75tvl6fJiL5gBXcVc7sHG-Mvk69FPRcMPww
linkProvider Wiley-Blackwell
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9wwEB7SpK9LH-lr27Sdlh5yMbEteWVDLmG325RullK2kJvRyyGwsUOSLaSn_oRA_mF_SUay7BLaQqE3GY8sIc2MPkujbwDeaUs_XZrxiNs8i7gwVSSN1JEySVwVsZJKeRLXqZjN8v394vMKbHd3YVp-iH7DzVmG99fOwN2G9NYv1tADrV0YMxM3YI2TGpF-r42_TL5Oe09Mq2_WshFkEemt6JiF4nSrr3x9PfoNZF7HrH7Rmdz_v-4-gHsBbOJOqx0PYcXW63CrTT95vg6398LB-iO4HPtIDmwqlNhGh1uDNXnunz8uDjw1tZtBHM92MERf05qH5ErsAgn34nGX8gPnVMMdB-DinDSlUQTPqfnwdERfb3BZu6RHCwwMUChrgw35rqPD7xb70PfHMJ-8n492o5CvIdLM-arKMK1yLllhbZUkirAWlQrBpDWEo2QuVV4IqWOZZ5JxUVUZr4RMtLRZMZTsCazWTW2fAToKGyYyU6jcQc4kJxyp7NAQWjKcMNMANrtJK3XgMncpNRZly8KcljTapR_tAbztRY9bAo8_CW10M18GGz4t06EjByS8lA7gTf-arM-NIQ1vs3QyLBfckegN4GmrMX0rBG0FwfGYOusV4-_Nlx9GI194_u-ir-HO7nxvWk4_zj69gLupu5Xh4xI3YPXsZGlfwk397ezw9ORVsIordZ0SwQ
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1ba9RAFD7UrRZfvNTb2qqj-OBLaJKZdCbQl7LrqrguRVboW5hrKWyTpe0K9cmfUOg_9Jd4ZjKJFBUE3xIykxnm3L5kznwH4LW2-NGlKUuYFUXCuHGJNFInymSpK1MllQokrlM-m4nDw_JgDfa6szAtP0T_w81bRvDX3sDt0ridX6yhR1r7NGbKb8A680VkBrA-_jz5Mu09MUbfomUjKBLUW94xC6X5Tt_5ejz6DWRex6wh6Ezu_t9078GdCDbJfqsd92HN1ptwqy0_ebEJG5_ixvoDuBqHTA7SOCJJmx1uDanRc__4fnkUqKm9BMl4tk9i9jXGPIKuxC4I4l6y7Ep-kDn28NsBZHGBmtIohOc4fLw7wbc3ZFX7okcLEhmgiKwNadB3nRx_s6RPfX8I88nb-eh9Eus1JJp6X-UM1UowSUtrXZYpxFp4VXIqrUEcJYVUouRSp1IUkjLuXMEcl5mWFsUn6SMY1E1tnwDxFDaUF6ZUwkPOTCCOVHbXIFoyDDHTEN50Qqt05DL3JTUWVcvCnFe42lVY7SG86psuWwKPPzXa7iRfRRs-q_JdTw6IeCkfwsv-MVqfX0Nc3mbl21DBmSfRG8LjVmP6URDacoTjKU42KMbfh6_ejUbh4um_N30BGwfjSTX9MPu4BbdzfygjpCVuw-D8dGWfwU399fz47PR5NIqf5tYSPA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Design+of+a+targeted+next-generation+DNA+sequencing+panel+for+pediatric+T-cell+lymphoblastic+lymphoma+to+unravel+biology+and+optimize+treatment&rft.jtitle=Genes+chromosomes+%26+cancer&rft.au=Ruether%2C+Charlotte&rft.au=Wuensch%2C+Christian&rft.au=Randau%2C+Gerrit&rft.au=Michgehl%2C+Ulf&rft.date=2022-08-01&rft.issn=1098-2264&rft.eissn=1098-2264&rft.volume=61&rft.issue=8&rft.spage=459&rft_id=info:doi/10.1002%2Fgcc.23037&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1045-2257&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1045-2257&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1045-2257&client=summon